Mumbai, September 28: Pharma major Sun Pharmaceuticals has entered into an exclusive lincensing agreement with US based LIB Therapeutics to develop and commercialise lerodalcibep, a third-generation PCSK9 inhibitor designed to...
Mumbai: After placing a non-binding, $10 billion bid for US-based women’s pharma specialty player Organon, Dilip Sanghavi-led Sun Pharma has upped its bid for the company. According to a report in...
Mumbai: India’s largest pharmaceutical company, Sun Pharmaceuticals, has placed a non-binding offer of about $10 billion to acquire US-based women’s health and speciality pharma company Organon. If this deal goes...
